DUBLIN–(BUSINESS WIRE)–The “Global Markets for Emerging Medical Device Technologies 2020-2025” report has been added to ResearchAndMarkets.com’s offering.
The global market for emerging medical device technologies should grow from $81.9 billion in 2020 to $146.2 billion by 2025, at a compound annual growth rate (CAGR) of 12.3% for the period of 2020-2025.
Companies Mentioned
- 3M
- Abbott Laboratories
- Agilent Technology Inc.
- Allergan Plc
- Amarantus Bioscience Holdings Inc.
- AMD Lasers LLC
- American Association For Cancer Research (AACR)
- American Society For Reproductive Medicine (ASRM)
- American Society Of Clinical Oncology (ASCO)
- Biolase Inc.
- Biomerieux S.A.
- Bioness Inc.
- Bioronik Se & Co. Kg
- Biosense Webster Inc.
- Boston Scientific Corp.
- Bracco
- Cardinal Health
- Center For Devices and Radiological Health (CDRH)
- Centers For Medicare & Medicaid Services (CMS)
- Colibri Heart Valve
- Cook Medical
- Cordis Corp.
- Edwards Lifesciences Corp.
- Endologix
- Eudamed
- Food And Drug Administration (FDA)
- GE Healthcare
- Global Cancer Foundation
- HLT Medical, Inc.
- Hologic Inc.
- And Many More Companies!
Traditional medical devices include devices (e.g., metallic stents, heart valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, needle-based drug delivery, lab-based diagnostics, etc.) that have been in use over the last 30 years for the treatment and management of various diseases.
Emerging medical device technologies include devices and technologies (e.g., bioresorbable implants, coated implants and balloons, transcatheter heart valves (TAVR, TMVR), electrophysiology, S-ICDs, cardioMEMS, wireless monitoring, wearable devices, needle-free drug delivery, capsule endoscopes, POC tests, companion diagnostics, etc.
The Report Includes
- 111 tables
- An overview of the global markets for emerging medical device technologies
- Analyses of global market trends, with data from 2019, 2020, 2021 and projections of compound annual growth rates (CAGRs) through 2025
- Evaluation of the market’s dynamics, specifically growth drivers, inhibitors, and opportunities
- Analyses of segments within the overall market including aesthetics/dermatology, cardiovascular, dental, diabetes care, gastroenterology, nephrology, urology, gynecology/women’s health, medical imaging/visualization, in-vitro diagnostics, neurology, ophthalmology, orthopedic, drug delivery/pain management, surgical/wound care and patient management/monitoring
- An in-depth look at growth driving factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years, technological advancements in medical devices, and the growing aging population
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Companies that are looking to invest funds in the medical device sector ought to strongly consider high-growth segments such as electrophysiology, bioresorbable vascular scaffold (BVS), transcatheter heart valve therapy and drug-coated balloons (DCB) in the cardiovascular market; point-of-care diagnostics (POCs)q, companion diagnostics and advanced cancer molecular diagnostics in the in vitro diagnostics market; and smart pills (capsule endoscopes, etc.) in the GI endoscopy market. Most of these segments are expected to have double-digit growth rates in the next five years. The increasing burden of diseases such as cardiovascular diseases, diabetes and cancer, and the growing adoption of advanced medical technologies are the key growth drivers.
The rising demand for imaging in the diagnosis and monitoring of chronic diseases is a major contributor to the growth of the global market for emerging medical devices. A shift toward minimally invasive procedures and rising adoption of hybrid operating rooms are also providing traction for the market. Secondary factors such as the increasing number of surgical procedures and high growth in patient care devices are also driving the market.
There is increased demand for advanced medical devices in cardiology and oncology. Heart valve replacement is the most common procedure in cardiology. Transcatheter aortic valve replacement is a minimally invasive heart valve replacement procedure. Positioning the new heart valve is a concern for surgeons. Due to the importance of positioning, surgeons prefer 3-D angiography imaging devices to view the anatomy during the placement of heart valves. As the number of heart surgeries increases worldwide, the use of advanced medical devices is expected to increase over the forecast period.
According to the World Health Organization (WHO), cardiovascular diseases, cancers, respiratory diseases and diabetes account for more than 80% of all premature non-communicable disease (NCD) deaths. NCDs claim 40 million victims each year and account for approximately 70% of global deaths. 3-D imaging devices are increasingly used in oncology and radiology.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Emerging Cardiovascular Device Technologies
Chapter 4 Emerging Device Technologies in the Orthopedic Market
Chapter 5 Emerging Device Technologies in Neurology
Chapter 6 Emerging Device Technologies in Diabetes Care
Chapter 7 Emerging Technologies In Vitro Diagnostics
Chapter 8 Needle-Free Drug Delivery Technologies
Chapter 9 Emerging Device Technologies in GI Endoscopy
Chapter 10 Other Emerging Medical Device Technologies
Chapter 11 COVID-19 Ushers in New Era of Medical Device Industry
Chapter 12 Regulatory Structure
Chapter 13 Pricing and Reimbursement
Chapter 14 Conclusions: Outlook for Emerging Medical Device Technologies
Chapter 15 Company Profiles
Chapter 16 Appendix A: Industry And Professional Organizations
Chapter 17 Appendix B: Abbreviations
For more information about this report visit https://www.researchandmarkets.com/r/bzdqcj
